Screening:
There is no
universally agreed protocol for screening people who have been exposed to
asbestos. Screening tests might diagnose mesothelioma earlier than conventional
methods thus improving the survival prospects for patients. The serum
osteopontin level might be useful in screening asbestos-exposed people for
mesothelioma. The level of soluble mesothelin-related protein is elevated in
the serum of about 75% of patients at diagnosis and it has been suggested that
it may be useful for screening. Doctors have begun testing the Mesomark assay
which measures levels of soluble mesothelin-related proteins (SMRPs) released
by diseased mesothelioma cells.
No comments:
Post a Comment